Development of renal cell carcinoma in living donor kidney grafts. Transplantation 2000; 70:1650

Transplantation

Volumn 70, Issue 11 SUPPL., 2000, Pages 1552-1553

  Marco, M ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE;

CANCER RISK; CARCINOGENESIS; COST BENEFIT ANALYSIS; ECHOGRAPHY; HORMONAL THERAPY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY CARCINOMA; KIDNEY TRANSPLANTATION; LIVING DONOR; MORBIDITY; NOTE; PRIORITY JOURNAL; CHILD; KIDNEY TUMOR; PATHOLOGY; PRESCHOOL CHILD; RISK FACTOR;

CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; HUMANS; KIDNEY NEOPLASMS; KIDNEY TRANSPLANTATION; LIVING DONORS; RISK FACTORS;

EID: 0034671125     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200012150-00002     Document Type: Note

References (8)

1. Renal cortical neoplasms in long term survivors of solid organ transplantation
2. Primary adenocarcinoma of the renal transplant
3. De novo malignancies in paediatric organ transplant recipients
4. Growth hormone replacement and the risk of malignancy children with Neurofibromatosis
5. Growth and growth hormone status following treatment for childhood leukaemia
6. Growth hormone therapy and malignancy
7. Primary adenocarcinoma of the renal transplant